Literature DB >> 29045916

Suicide deaths among patients with end-stage renal disease receiving dialysis: A population-based retrospective cohort study of 64,000 patients in Taiwan.

I-Ming Chen1, Po-Hsien Lin2, Vin-Cent Wu3, Chi-Shin Wu4, Jia-Chi Shan5, Shu-Sen Chang6, Shih-Cheng Liao7.   

Abstract

BACKGROUND: Patients with end-stage renal disease (ESRD) who receive dialysis may experience increased distress and risk of suicide.
METHODS: This population-based retrospective cohort study linked Taiwan's national register of ESRD patients on dialysis and the cause-of-death mortality data file. A separate multiple-cause-of-death data file was used to investigate the detailed suicide methods used. Standardized mortality ratios (SMRs) were calculated for the overall patient group and by sex, age, year of initiating dialysis, method of suicide, and time since initiation of dialysis.
RESULTS: Among 63,854 ESRD patients on dialysis, 133 died by suicide in Taiwan in 2006-2012; the suicide rate was 76.3 per 100,000 patient-years. The SMR for suicide was 2.38 (95% confidence interval [CI] 1.99-2.82) in this patient group. Suicide risk was highest in the first year of dialysis (SMR = 3.15, 95% CI 2.39-4.08). The risk of suicide by cutting was nearly 20 times (SMR = 19.91, 95% CI 12.88-29.39) that of the general population. Detailed information on death certificates indicated that three quarters of patients who killed themselves by cutting cut vascular accesses used for hemodialysis. LIMITATIONS: Information on risk factors such as socioeconomic position and mental disorders was unavailable.
CONCLUSION: In a country where the national health insurance program covers most expenses associated with dialysis treatment, the suicide risk in ESRD patients on dialysis still increased nearly 140%. Adequate support for ESRD patients initiating dialysis and the assessment of risk of cutting vascular access as a potential means of suicide could be important strategies for suicide prevention.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cutting; Dialysis; End-stage renal disease; Suicide; Suicide method

Mesh:

Year:  2017        PMID: 29045916     DOI: 10.1016/j.jad.2017.10.020

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Gender and age differences in the association between work stress and incident depressive symptoms among Korean employees: a cohort study.

Authors:  Sun-Young Kim; Young-Chul Shin; Kang-Seob Oh; Dong-Won Shin; Weon-Jeong Lim; Sung Joon Cho; Sang-Won Jeon
Journal:  Int Arch Occup Environ Health       Date:  2019-12-03       Impact factor: 3.015

2.  Role of resilience and social support in alleviating depression in patients receiving maintenance hemodialysis.

Authors:  Yueh-Min Liu; Hong-Jer Chang; Ru-Hwa Wang; Li-King Yang; Kuo-Cheng Lu; Yi-Chou Hou
Journal:  Ther Clin Risk Manag       Date:  2018-03-01       Impact factor: 2.423

3.  Exploring demands of hemodialysis patients in Taiwan: A two-step cluster analysis.

Authors:  I-Chen Yu; Ji-Tseng Fang; Yun-Fang Tsai
Journal:  PLoS One       Date:  2020-02-07       Impact factor: 3.240

Review 4.  Experimental models in peritoneal dialysis (Review).

Authors:  Bo Yang; Mengmeng Wang; Xue Tong; Ghada Ankawi; Lin Sun; Hongtao Yang
Journal:  Exp Ther Med       Date:  2021-01-21       Impact factor: 2.447

5.  Self-reported chronic kidney disease and the risk of all-cause and cause-specific mortality: outcome-wide association study of 54 causes of death in the National Health Interview Survey.

Authors:  Dagfinn Aune; Xibin Sun; Jing Nie; Wentao Huang; Bing Liao; Yafeng Wang
Journal:  BMC Nephrol       Date:  2022-04-30       Impact factor: 2.585

6.  Effect of Bright Light Therapy on Depressive Symptoms in Middle-Aged and Older Patients Receiving Long-Term Hemodialysis.

Authors:  Shu-Yi Huang; Malcolm Koo; Tsung-Cheng Hsieh; Ru-Ping Lee; Huei-Chuan Sung
Journal:  Int J Environ Res Public Health       Date:  2020-10-23       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.